GeneDx Holdings (WGS) reported a Q1 loss Wednesday of $0.23 per share, narrowing from a loss of $0.78 a year earlier.
Two analysts polled by FactSet expected a loss of $0.27 per share.
Revenue for the quarter ended March 31 was $87.1 million, up from $62.4 million a year earlier.
Analysts surveyed by FactSet expected $79.5 million.
The company said it now expects full-year revenue of $360 million to $375 million compared with its prior guidance of $350 million to $360 million. Analysts polled by FactSet expect $358.9 million.
Shares of the company were down more than 27% in recent Wednesday premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。